Literature DB >> 22622176

The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients.

J M Halimi1.   

Abstract

The natural history of diabetic nephropathy was defined in the 1980s on the basis of longitudinal studies undertaken in patients with type 1 and type 2 diabetes. However, an increasing number of studies have indicated that certain diabetic patients do not present with the same evolution as was then defined: for example, some often have significant initial deterioration of glomerular filtration rate whereas, in others, microalbuminuria is reduced spontaneously. Chronic kidney disease (CKD) may be accompanied, rather than preceded, by macroalbuminuria, or it may develop in patients with microalbuminuria or even in those with albuminuria levels that revert to normal. CKD can also develop in patients whose albuminuria levels remain normal. Progression to macroalbuminuria is, in fact, less frequent than regression to normoalbuminuria or no change in microalbuminuria status in diabetic patients with microalbuminuria, especially in type 1 diabetes. Some experience progressive deterioration of renal function due to diabetes without developing significant proteinuria: this is seen fairly frequently and can affect 50% of patients with renal insufficiency. Such cases are more often older patients treated with renin-angiotensin system blockers who usually have a history of cardiovascular disease. Evolution to end-stage renal disease is slower in this subgroup of patients, although histological analyses may show surprisingly advanced glomerular lesions. The main parameters of surveillance remain regular monitoring of glycaemia, and control of blood pressure and the evolution of initial albuminuria levels. Nevertheless, why some patients exhibit conventional diabetic nephropathy while others have slower declines in renal function associated with normal albuminuria levels or microalbuminuria is unclear. It is hoped that the new pathological classification of diabetic nephropathy will help in our understanding of these discrepancies.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622176     DOI: 10.1016/j.diabet.2012.04.001

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  31 in total

Review 1.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

Review 2.  Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study.

Authors:  Giorgina Barbara Piccoli; Roberta Clari; Sara Ghiotto; Natascia Castelluccia; Nicoletta Colombi; Giuseppe Mauro; Elisabetta Tavassoli; Carmela Melluzza; Gianfranca Cabiddu; Giuseppe Gernone; Elena Mongilardi; Martina Ferraresi; Alessandro Rolfo; Tullia Todros
Journal:  Rev Diabet Stud       Date:  2013-05-10

3.  The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus.

Authors:  R Har; J W Scholey; D Daneman; F H Mahmud; R Dekker; V Lai; Y Elia; M L Fritzler; E B Sochett; H N Reich; D Z I Cherney
Journal:  Diabetologia       Date:  2013-02-15       Impact factor: 10.122

Review 4.  Diabetic kidney disease: from physiology to therapeutics.

Authors:  Carmen Mora-Fernández; Virginia Domínguez-Pimentel; Mercedes Muros de Fuentes; José L Górriz; Alberto Martínez-Castelao; Juan F Navarro-González
Journal:  J Physiol       Date:  2014-06-06       Impact factor: 5.182

5.  Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.

Authors:  Zeyu Zhang; Maolin Luo; Yongping Lu; Weifeng Feng; Hongwei Wu; Lijing Fan; Baozhang Guan; Yong Dai; Donge Tang; Xiangnan Dong; Chen Yun; Berthold Hocher; Haiping Liu; Qiang Li; Lianghong Yin
Journal:  Int Urol Nephrol       Date:  2022-10-18       Impact factor: 2.266

Review 6.  Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.

Authors:  Giorgina B Piccoli; Giorgio Grassi; Gianfranca Cabiddu; Marta Nazha; Simona Roggero; Irene Capizzi; Agostino De Pascale; Adriano M Priola; Cristina Di Vico; Stefania Maxia; Valentina Loi; Anna M Asunis; Antonello Pani; Andrea Veltri
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 7.  Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.

Authors:  Gianfranco Tramonti; Yashpal S Kanwar
Journal:  Endocrine       Date:  2012-10-20       Impact factor: 3.633

8.  The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus.

Authors:  L-H Chang; C-M Hwu; C-H Chu; Y-C Lin; C-C Huang; J-Y You; H-S Chen; L-Y Lin
Journal:  J Endocrinol Invest       Date:  2021-04-08       Impact factor: 4.256

Review 9.  Regulation of Monocytes/Macrophages by the Renin-Angiotensin System in Diabetic Nephropathy: State of the Art and Results of a Pilot Study.

Authors:  Claudine Moratal; Audrey Laurain; Mourad Naïmi; Thibault Florin; Vincent Esnault; Jaap G Neels; Nicolas Chevalier; Giulia Chinetti; Guillaume Favre
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

10.  Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.

Authors:  Nishant M Bhensdadia; Kelly J Hunt; Maria F Lopes-Virella; J Michael Tucker; Mohammad R Mataria; Joseph L Alge; Benjamin A Neely; Michael G Janech; John M Arthur
Journal:  Kidney Int       Date:  2013-03-27       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.